Wims Morris Leslie 4
4 · IQVIA HOLDINGS INC. · Filed Feb 11, 2026
Research Summary
AI-generated summary of this filing
IQVIA (IQV) Director Leslie Wims Morris Receives 159 Deferred Shares
What Happened Leslie Wims Morris, a director of IQVIA Holdings Inc. (IQV), received an award of 159 deferred shares on 2026-02-09. The grant is recorded at $192.67 per share for a total notional value of $30,635. This was an award/acquisition of a derivative security (deferred share), not an open-market purchase or sale of common stock.
Key Details
- Transaction date and price: 2026-02-09; 159 deferred shares at $192.67 each (total $30,635).
- Transaction type/code: A — award/grant (derivative security).
- Shares owned after transaction: Not specified in the filing.
- Filing date/timeliness: Form 4 filed 2026-02-11 (covers the 2026-02-09 transaction), filed within the standard reporting window.
- Footnote: Deferred shares are convertible into one share of IQV common stock upon settlement under the Non-Employee Director Deferral Plan; settlement occurs when the director leaves the board, upon a change in control, or upon death. There is no expiry date.
Context Deferred-share awards are commonly used to compensate non-employee directors and are not immediately tradable stock. Because these are settlement-timed, they do not represent an immediate increase in circulating shares and should not be read as an immediate bullish or bearish trade signal.
Insider Transaction Report
Form 4
Wims Morris Leslie
Director
Transactions
- Award
Deferred Shares
[F1]2026-02-09$192.67/sh+159$30,635→ 4,894 total→ Common Stock (159 underlying)
Footnotes (1)
- [F1]Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.
Signature
/s/ Matthew Gilmartin, Attorney-in-Fact for Leslie Wims Morris|2026-02-11